Lorlatinib Salvages Central Nervous System-Only Relapse on Entrectinib in ROS1-Positive NSCLC.

Coleman, Niamh; Yousaf, Nadia; Arkenau, Hendrik-Tobias; Welsh, Liam; Popat, Sanjay

Coleman, Niamh; Yousaf, Nadia; Arkenau, Hendrik-Tobias; Welsh, Liam; Popat, Sanjay.

Afiliação

Coleman N; Lung Unit, The Royal Marsden Hospital, London, United Kingdom; Institute of Cancer Research, London, United Kingdom.
Yousaf N; Lung Unit, The Royal Marsden Hospital, London, United Kingdom.
Arkenau HT; Sarah Cannon Research Institute, London, United Kingdom.
Welsh L; Neuro-oncology Unit, The Royal Marsden Hospital, London, United Kingdom.
Popat S; Lung Unit, The Royal Marsden Hospital, London, United Kingdom; Institute of Cancer Research, London, United Kingdom. Electronic address: sanjay.popat@rmh.nhs.uk.

J Thorac Oncol ; 15(8): e142-e144, 2020 08.

Article em En | MEDLINE | ID: mdl-32718541

Assuntos

Neoplasias Pulmonares; Proteínas Tirosina Quinases; Aminopiridinas; Benzamidas; Sistema Nervoso Central; Humanos; Indazóis; Lactamas; Lactamas Macrocíclicas; Neoplasias Pulmonares/tratamento farmacológico; Recidiva Local de Neoplasia; Proteínas Proto-Oncogênicas; Pirazóis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Tirosina Quinases / Neoplasias Pulmonares Limite: Humans Idioma: En Revista: J Thorac Oncol Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google